{"database": "lobbying", "table": "lobbying_activities", "rows": [[1226070, "e3b9698f-b159-4923-bdeb-9e5aa7d1fb0c", "Q1", "DENNY MILLER ASSOCIATES", 25328, "CELL THERAPEUTICS", 2012, "first_quarter", "MED", "FDA appeal process for new drug applications.  Prescription Drug and User Fee Act Reauthorization (no number), provisions relating to approval of new drugs.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2012-04-13T10:03:25.597000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1226070"], "units": {}, "query_ms": 0.4679560079239309, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}